ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

VCYT Veracyte Inc

22,73
-0,67 (-2,86%)
18 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Veracyte Inc VCYT NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,67 -2,86% 22,73 01:00:07
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
23,44 22,85 23,47 22,88 23,40
mais cotações »

Notícias Recentes

Data Hora Fonte Título
15/05/202418:04BWVeracyte to Participate in Upcoming Investor Conferences
07/05/202417:05BWVeracyte Announces First Quarter 2024 Financial Results
06/05/202417:05BW14 Studies Presented at AUA 2024 Show Decipher Tests’..
22/04/202418:00BWVeracyte to Release First Quarter 2024 Financial Results on..
22/04/202409:30BWNew Study Shows Veracyte’s Decipher Prostate Test is..
16/04/202409:30BWVeracyte Announces that Nine Studies Reinforcing the Value..
27/02/202419:55BWVeracyte’s Decipher Prostate Test Receives Highest..
22/02/202418:05BWVeracyte Announces Fourth Quarter and Full-Year 2023..
21/02/202419:00BWVeracyte to Participate in the Raymond James 45th Annual..
08/02/202410:00BWVeracyte to Release Fourth Quarter and Full-Year 2023..
06/02/202410:15BWVeracyte Completes Acquisition of C2i Genomics
08/01/202410:00BWVeracyte Announces Preliminary Full-Year 2023 Results,..
12/12/202318:30BWVeracyte to Participate in the 42nd Annual J.P. Morgan..
01/12/202318:05BWReal-World Data Presented at SUO 2023 Show that Veracyte’s..
29/11/202310:30BWClinical Validation Data Published in CHEST Demonstrate that..
22/11/202310:30BWVeracyte Announces Seven Posters Highlighting Clinical Value..
07/11/202318:05BWVeracyte Announces Third Quarter 2023 Financial Results
07/11/202318:00BWVeracyte Announces In Vitro Diagnostic Agreement with..
02/11/202309:15BWVeracyte to Participate in the Stephens Annual Investment..
27/10/202309:30BWVeracyte Announces SITC 2023 Presentations Offering New..
17/10/202309:15BWVeracyte to Release Third Quarter 2023 Financial Results on..
12/10/202310:00BWNew Data Presented at CHEST 2023 Demonstrate the Clinical..
04/10/202317:05BWNew Data from Phase 3 Trial Further Validate Prognostic..
28/09/202317:05BWNew Data Presented at the 2023 ATA Annual Meeting..
28/09/202309:15BWVeracyte Announces Multiple Studies Reinforcing the Value of..
27/09/202310:00BWVeracyte Names Phillip G. Febbo, M.D., as Chief Scientific..
21/09/202317:05BWVeracyte Announces Novel Afirma-Based Findings that Advance..
07/09/202317:05BWVeracyte Names Marie-Claire Taine, Ph.D., as General Manager..
06/09/202309:15BWVeracyte and Gustave Roussy Announce Collaboration to Help..
29/08/202309:15BWVeracyte to Participate in the Morgan Stanley 21st Annual..
22/08/202309:15BWVeracyte Announces that Findings Published in JCO Precision..
15/08/202317:15BWVeracyte Earns Top Workplace Awards in the San Francisco Bay..
08/08/202317:05BWVeracyte Announces Second Quarter 2023 Financial Results
01/08/202309:15BWStudy Published in JNCI Cancer Spectrum Demonstrates..
19/07/202318:00BWVeracyte to Release Second Quarter 2023 Financial Results on..
20/06/202309:31BWNew Data Suggest Veracyte’s Afirma Molecular Testing..
12/06/202309:31BWVeracyte Announces Afirma-Focused Abstracts to Be Presented..
25/05/202318:13BWNew Data To Be Shared at 2023 ASCO Demonstrate Power of..
24/05/202310:00BWNew Data Presented at ATS 2023 Reinforce Clinical Utility of..
23/05/202318:00BWVeracyte to Participate in Upcoming Investor Conferences